Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 26, Issue 1, Pages 8-9Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2004.10.010
Keywords
-
Categories
Funding
- Intramural NIH HHS [Z01 DK031116-20] Funding Source: Medline
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK031116] Funding Source: NIH RePORTER
Ask authors/readers for more resources
The P2Y receptor family currently encompasses eight members (P2Y(1,2,4,6,11,12,13,14) receptors) that are activated by extracellular adenine and/or uracil nucleotides, or, in the case of the P2Y(14) receptor, by sugar-nucleotides, and are each characterized by the typical seven-transmembrane domain topology of G-protein-coupled receptors (GPCRs) [1]. For several years, it has been known that a series of 'orphan' GPCRs (i.e. cloned receptors available in the public database for which a natural ligand has not yet been identified) share significant sequence identity with the eight genuine P2Y receptors [1,2] and thus putatively represent novel members of the P2Y receptor family.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available